Recognition, funding and what we are building.
Formula-Y's approach has been supported through successive subsidies from SNN, the Just Transition Fund and the European Union. Here is what each programme set out to answer, and what came of it.
SNN · Just Transition Fund · European UnionOngoing · 2026 to 2027
VIA Groningen 2025 to 2026: Proof of concept for AI-designed antibodies
Our current flagship project: building and testing the proof of concept for Formula-Y's AI-driven antibody design, on the way to a validated design service.
Read the projectSNN · MIT Haalbaarheid 2025Feasibility study
MIT Haalbaarheid 2025: AI for target identification
A feasibility study into whether AI can make target identification, the first and most consequential choice in any antibody program, faster, cheaper and more systematic.
Read the studySNN · MIT HaalbaarheidCompleted 2024
MIT Haalbaarheid 2023: Proving the case for AI-designed antibodies
The feasibility study that started it all: a structured technical and economic assessment confirming that AI-driven antibody design is both viable and worth building.
Read the studySupported by
